Long-term anti-arrhythmic is effective than no anti-arrhythmic in patients with first developed paroxysmal atrial fibrillation

Back

EHRA Premium Access

Long-term anti-arrhythmic is effective than no anti-arrhythmic in patients with first developed paroxysmal atrial fibrillation

Session: Poster session on atrial fibrillation and supraventricular tachycardia

Topic: Rhythm Control, Antiarrhythmic Drugs

Speaker: Professor Y. Park (Incheon, KR)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Professor Yae Min Park

Gachon University Gil Medical Center, Incheon (Korea (Republic of))

1 presentation

0 follower

116 more presentations in this session

Left atrial strain measurement in patients with heart failure and atrial fibrillation compared to a control group

Speaker: Doctor L. Herzer (Jena, DE)

Atrial fibrillation after transcatheter tricuspid valve repair: rhythm control strategies and outcomes

Speaker: Doctor J. Schipper (Cologne, DE)

Access

Abstract

Left atrial strain defines functional and structural remodeling in patients with persistent atrial fibrillation

Speaker: Doctor A. Grosse (Jena, DE)

Cryoballoon ablation for atrial fibrillation in young adults: a propensity-score matching comparison with an older cohort

Access

Procedural safety and outcome of additional left atrial posterior wall ablation using pulse field ablation for atrial fibrillation

Speaker: Doctor J. Tay Cheong Kiat (Singapore, SG)

Access the full session

Poster session on atrial fibrillation and supraventricular tachycardia

Speakers: Professor Y. Park, Doctor L. Herzer, Doctor J. Schipper, Doctor A. Grosse, Doctor J. Tay Cheong Kiat

Access

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources